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Abstract
Background: The use of compulsory treatment under the Mental Health Act (MHA) has continued to rise in the
UK and in other countries. The Joint Crisis Plan (JCP) is a statement of service users’ wishes for treatment in the
event of a future mental health crisis. It is developed with the clinical team and an independent facilitator. A
recent pilot RCT showed a reduction in the use of the MHA amongst service users with a JCP. The JCP is the only
intervention that has been shown to reduce compulsory treatment in this way. The CRIMSON trial aims to
determine if JCPs, compared with treatment as usual, are effective in reducing the use of the MHA in a range of
treatment settings across the UK.
Methods/Design: This is a 3 centre, individual-level, single-blind, randomised controlled trial of the JCP compared
with treatment as usual for people with a history of relapsing psychotic illness in Birmingham, London and
Lancashire/Manchester. 540 service users will be recruited across the three sites. Eligible service users will be adults
with a diagnosis of a psychotic disorder (including bipolar disorder), treated in the community under the Care
Programme Approach with at least one admission to a psychiatric inpatient ward in the previous two years. Current
inpatients and those subject to a community treatment order will be excluded to avoid any potential perceived
pressure to participate. Research assessments will be conducted at baseline and 18 months. Following the baseline
assessment, eligible service users will be randomly allocated to either develop a Joint Crisis Plan or continue with
treatment as usual. Outcome will be assessed at 18 months with assessors blind to treatment allocation. The primary
outcome is the proportion of service users treated or otherwise detained under an order of the Mental Health Act
(MHA) during the follow-up period, compared across randomisation groups. Secondary outcomes include overall
costs, service user engagement, perceived coercion and therapeutic relationships. Sub-analyses will explore the
effectiveness of the JCP in reducing use of the MHA specifically for Black Caribbean and Black African service users
(combined). Qualitative investigations with staff and service users will explore the acceptability of the JCPs.
Discussion: JCPs offer a potential solution to the rise of compulsory treatment for individuals with psychotic
disorders and, if shown to be effective in this trial, they are likely to be of interest to mental health service
providers worldwide.
Trial registration: Current Controlled Trials ISRCTN11501328
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Background
Two of the key guiding principles of mental health policy
in England are that service users should: (i) exercise choice
and control over their treatment [1], and (ii) be subjected
to the least restrictive form of care. Service users now rou-
tinely participate in care planning, service development
and research. Nevertheless, against the European trend [2],
the use of compulsory treatment in England has continued
to rise [3]. This conflicts with government policy and ser-
vice user preferences given that many service users find
in-patient wards counter-therapeutic [4].
In England, in addition to the general concern about
rising rates of compulsory treatment, there is additional
concern that Black African and Black Caribbean service
users experience more coercive mental health care than
their white counterparts [5-8]. So far no interventions
have been identified which reduce compulsory mental
health treatment for Black Caribbean and Black African
service users.
A Joint Crisis Plan (JCP) aims to empower service
users whilst facilitating early detection and treatment of
relapse [9,10]. It is developed by the mental health ser-
vice user in collaboration with staff. Held by the service
user, it contains his or her treatment preferences for any
future psychiatric emergency, when he or she may be
too unwell to express clear views. The JCP format has
developed over the last decade after widespread consul-
tation with national service user groups, interviews with
organisations and individuals using JCPs, and detailed
developmental work with service users in South London
[9,10]. Initial findings from the pilot study suggest that
the negotiation process itself helps engage the service
user and the clinician in a more acceptable, collabora-
tive, and beneficial therapeutic relationship.
JCPs are somewhat similar to Psychiatric Advance
Directives (PAD) and Facilitated Advance Directives
(F-PADs) that have been developed in the United States
(see [11]). Non-Randomised studies from the United
States suggest that PADs are popular with service users
[12,13] and generate clinically relevant information [14].
From a randomised trial, there is also preliminary evi-
dence to suggest that F-PADs may improve therapeutic
relationships between service users and clinicians [15]
and reduce coercive crisis interventions such as police
transport, forced medication, use of seclusion and
restraints, and involuntary commitment [16]. However,
JCPs differ from the F-PADs and PADs in two impor-
tant ways: firstly, JCPs require the direct involvement of
the clinical team in helping the service user decide the
content of the JCPs; and secondly JCPs do not have the
same degree of medico-legal enforceability [11]; advance
refusals of treatment must be respected under the terms
of the Mental Capacity Act 2005 but can be over-ridden
by use of an involuntary treatment order under the
Mental Health Act (1983).
Two studies have produced findings that suggest that
JCPs might reduce compulsory treatment and improve-
ment therapeutic relationships. A pilot study of JCPs
conducted by the authors in South London [9] showed
that at 6 to 12 month follow-up, 57% of participating
psychiatric service users with JCPs reported feeling
more involved in their care, 60% were positive about
their situation, 51% felt more in control of their mental
health problem and 41% felt they were more likely to
continue treatment. Further, an exploratory randomised
study of JCPs [17], found that use of the MHA was sig-
nificantly reduced for the intervention group, 10/80
(12.5%) of whom experienced compulsion versus 21/80
(26.5%) of the control group (risk ratio 0.48, 95% CI
0.24 to 0.95, p = 0.028). While overall bed-day use was
not significantly different between experimental and
control groups, the mean number of days compulsorily
detained under the Mental Health Act (1983) for the
intervention group during the 15 month follow-up per-
iod was 14 compared to 31 for the control group (differ-
ence 16, 95% CI 0 to 36, p = 0.04). In summary,
coercive treatment in the form of MHA use was halved
by the use of JCPs: the first structured clinical interven-
tion shown to reduce compulsion in mental health ser-
vices. JCPs are relatively straightforward to implement,
and offer the prospect of less restrictive care for service
users with psychotic disorders. A more recent health
economic analysis of this trial has shown that the inter-
vention has a highly probability of being more cost-
effective than the control [18]. The time is therefore
right for a definitive trial.
The primary hypothesis to be tested is whether JCPs
significantly reduce the proportion of service users
detained or treated under a section of the MHA during
the 18 month follow-up period, compared with the con-
trol group. Secondary hypotheses will be to determine if
compared with the control condition, JCP use will result
in significant improvements in: total costs, perceived
coercion, service user engagement, therapeutic alliance.
Sub-analyses will examine the effectiveness of the JCP in
reducing use of the Mental Health Act for Black (Black
Caribbean and Black African) service users.
Methods/Design
This trial is funded by the Medical Research Council
(MRC). This trial has received ethical approval from
King’s College Hospital Research Ethics Committee.
Design
The CRIMSON trial is an individual-level single-blind
Randomised Controlled Trial of Joint Crisis Plans (JCPs)
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compared with a treatment as usual control for people
with a history of relapsing psychotic illness under the
care of community mental health teams in Birmingham,
London and Lancashire/Manchester. The total duration
of the study will be four years, to allow for: recruitment
to target; provision of the intervention; follow-up assess-
ments; qualitative exploration of use and acceptability of
the JCPs; and data analysis, using intention to treat
methods. Recruitment to the trial began in August 2008
and is due for completion in March 2010. Follow-up
assessments begin in February 2010 and will be com-
pleted by September 2011.
The intervention
The Joint Crisis Plan (JCP) intervention has been
described in some detail elsewhere [9-11], but is briefly
delineated here. At each site, a trained and clinically
experienced Facilitator will organise two meetings with
each service user randomised to receive a JCP. In the
first meeting, the Facilitator will introduce the JCP
‘menu’ (a list of topics to be considered for inclusion
in the JCP) to each service user. This first meeting will
occur in either the service user’s home or a local clini-
cal setting. The facilitator will then organise a subse-
quent planning meeting between the service user, team
consultant psychiatrist or other psychiatrist, and the
Care Co-ordinator, when the JCP contents will be fina-
lised. This planning meeting will be convened, usually
at the clinical base, a minimum of one week after the
preliminary meeting to enable the service user time to
consider their options. The service user is encouraged
to bring a carer or friend to act as an advocate to the
planning meeting. The JCP contains: information on
early warning signs of relapse and advance treatment
statements; contact details of primary and secondary
care staff for routine and emergency care; details of
medication; psychiatric and physical diagnoses; aller-
gies; and details of who will have a copy of the JCP. A
copy of the JCP is included on the computerised
patient information systems in routine use by the clini-
cal services. In addition, the Facilitator provides a
printed version of the JCP to all those specified by the
service user.
To ensure fidelity of the intervention at each site:
i) Facilitators will be experienced mental health pro-
fessionals who will receive rigorous training in negotiat-
ing joint crisis planning meetings, and producing JCPs;
ii) continual supervision by one of the developers of
the intervention (KS) will be provided;
iii) fidelity to the model will be formally assessed at
random intervals using a rating scale to evaluate audio-
tapes of meetings and copies of completed JCPs;
i) issues identified during supervision or fidelity assess-
ment will be ivmmediately addressed through further
training and supervision.
The control condition
We have chosen to use a treatment as usual (TAU) con-
trol condition, as this provides a fair comparison with
routine clinical practice, and will answer the question of
whether JCP use is superior to current standard care.
TAU includes, as a part of the Care Programme
Approach (CPA), the need for service users to receive
written copies of their care plan [19] including a ‘crisis
contingency plan’, as indeed was the case in our recent
exploratory trial. We expect that the CPA arrangements,
and the new 2006 Quality and Outcomes Framework
(QOF) (which requires a care plan to be documented in
primary care case records), will be applied equally to
intervention and control groups. The content of the
Care Programme Approach of all participants will be
assessed at baseline and follow-up.
Participants
Inclusion and Exclusion Criteria
Eligible service users will be adults (age 16+) and will
have: (i) contact with a local Community Mental Health
Team (CMHT) (including assertive outreach teams,
early intervention teams, and community forensic teams,
but not home treatment teams.); (ii) been admitted to a
psychiatric in-patient service at least once in the pre-
vious two years; (iii) a diagnosis of psychotic illness,
including bipolar affective disorder (using Operational
Criteria Checklist OPCRIT [20]), and (iv) been on the
local NHS Trust Enhanced CPA/CPA Register in the
last two years. We shall include service users who do
not speak English. For non-English speakers, both writ-
ten translation and interpreters are needed and we shall
employ interpreters as required.
We will exclude participants unable to give informed
consent. Additionally, current in-patients and those sub-
ject to a compulsory community treatment order will
not be recruited to avoid any perceived coercion to par-
ticipate. No other exclusions will be made to maximise
the external validity of the trial.
Recruitment and Randomisation
A list of eligible service users will be generated by Clini-
cal Studies Officers from the Mental Health Research
Network and maintained by the Study Co-ordinating
Centre. Each eligible person, with the agreement of the
clinical team, will be approached by a trained member
of the research team and invited to participate in the
study, thus eliminating selection biases. Once informed
consent has been obtained, trained researchers will con-
duct a baseline assessment and then follow-up each par-
ticipant 18 months later. The setting for the research
assessments will be the choice of the participant.
After the baseline assessment, participants will be ran-
domly allocated to either intervention or control group,
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stratified by centre using permuted blocks of randomly
varying block size, with equal allocation to the two
arms. To ensure concealment of allocation the randomi-
sation will be performed by an online system managed
by the Clinical Trials Unit at the Study Coordinating
Centre in London.
Assessments
At baseline and follow-up, service user socio-demographic
information (including education, employment, clinical
diagnoses and marital status) will be collected. Overall
functioning will be measured by Global Assessment of
Functioning (GAF) at baseline and follow-up assessments.
Information will be obtained from interviews with partici-
pants and case notes with the service user’s permission.
Additionally, some demographic information will be col-
lected on the service user’s care coordinator such as age,
qualifications and length of practice. All data will be col-
lected by research assistants blind to allocation. Mainte-
nance of blinding will be recorded and reported at the end
of the trial.
Primary Outcome Measure
The primary outcome is the proportion of service users
treated or otherwise detained under an order of the
Mental Health Act (MHA) during the follow-up period.
MHA data will be gathered from and validated between
the following sources: case notes, the local Patient
Administration System, Mental Health Act Office data,
and interviews with service users and Care Co-ordina-
tors (the latter being particularly important to pick up
out of area admissions). A sub-analysis of this data will
examine the proportion of Black service users treated or
detained under the MHA.
Secondary Outcome Measures
The secondary outcomes include mental hospital use
data, total costs, perceived coercion, engagement and
therapeutic relationships.
Hospital use data The proportion of service users
entering hospital voluntarily, the number of days spent
in hospital both voluntarily and under section, and time
to first admission will be compared between groups.
This data will be collected with the primary outcome
data.
Costs The economic evaluation will take a broad per-
spective and will be based on comprehensive resource
use data collected on all health, social care, housing and
other community support services used by individual
trial participants, contact with criminal justice agencies,
and other resources arising from the use of the MHA,
and productivity losses. Data will be collected in inter-
views with participants at baseline and follow-up using
the Adult Service Use Schedule (AD-SUS), a measure
designed by the applicants (SB) for collecting service use
data in mental health populations. Interview data will be
supplemented by data on hospital contacts, the key cost
driver in this population, collected from routine compu-
terised hospital records. Data on the time and staffing
required in undertaking the JCP intervention will be col-
lected from JCP facilitator records, as in our previous
trial [17].
Perceived Coercion Perceived coercion will be mea-
sured using an adapted version of the MacArthur Per-
ceived Coercion Scale. This scale has been adapted for
reference to outpatient treatment [21] and is designed
to ascertain participants’ experience of coercion during
treatment in the community. This is a self-report mea-
sure completed by the service user at baseline and fol-
low-up. Responses to this measure will be used to
generate three scales: ‘perceived coercion’, ‘negative
pressures’ and ‘process exclusion’.
Engagement Two measures of engagement will be com-
pleted by the care coordinator at baseline and follow-up.
The first measure is adapted from the Homeless
Engagement and Acceptance Scale [22]. The full scale
has five items. The adapted version drops the last item
that refers to homelessness. The second measure of
Engagement is the Service Engagement Scale [23]. This
is a 14 items scale producing four subscales measuring
‘availability’, ‘collaboration’, ‘help seeking’ and ‘treatment
adherence’. Both measures of engagement are rated by
the participant’s care coordinator.
Therapeutic relationship Both service users and staff
will complete the short version of the Working Alliance
Inventory adapted for use for individuals with severe
mental illness [15,24,25].
Recovery Style We will also examine participant recov-
ery styles with the Recovery Style Questionnaire (RSQ)
[26]. The RSQ has 39-items which are rated by the ser-
vice user. The RSQ is used to classify four recovery
styles: ‘Integration’; ‘Mixed picture in which integration
predominates’; ‘Mixed picture in which sealing over pre-
dominates’; and ‘Sealing over’.
Qualitative Analyses
Qualitative methods will be carried out to explore the
processes through which JCPs achieve change in prac-
tice. Pilot work suggests they have direct and indirect
effects. Negotiating JCP content may clarify treatment
issues and build consensus between service users and
staff. However other important effects may include
changes in: trust; service user engagement in the process
of care including shared decision making [27]; service
user self esteem and empowerment; channels of com-
munication between all parties; staff risk perception;
and/or changes within the culture of the mental health
service may also be important. Focus groups will be
used to examine people’s experience of the JCP. The
important ‘break characteristic’ used in data analysis will
be whether service users with a JCP were subject to
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MHA use. 18 focus groups (6 groups in each site) will
run 18-21 months after entry to the study.
We will conduct separate service user and health pro-
fessional focus groups with service users who have or
have not been treated under the Mental Health Act.
These groups will be followed, usually one week later, by
a combined subset of the service users and health profes-
sionals who attended the separate groups. We expect to
involve 16 service users in each geographical site and a
similar number of professionals involved in the develop-
ment of the JCP with the service user. Focus group topic
guides will be developed from a literature review and
include the themes discussed above. Combined groups
will additionally explore the roles and responsibilities of
service users and health care professionals in relation to
the use of the JCP and the influence on and impact of the
culture of mental health services.
To understand the experiences and views of psychia-
trists who have participated in the intervention, a series
of individual interviews will be conducted. Interviews
will cover the psychiatrist’s views on the process of the
intervention, the outcome and the impact of such an
intervention on mental health services. Interviews will
be conducted in all sites, and will continue until ‘data
saturation’ is achieved i.e., no further themes are
identified.
Focus groups and psychiatrist interviews will be audio
taped and fully transcribed. Transcripts and notes will
be read and re-read independently by two of the
research team. The data will then be organised into
initial codes and higher codes that provide insight into
emergent themes. For the focus groups, reliability will
be enhanced by identifying issues that are consistent
between groups and validated using so-called ‘sensitive
moments’ within group interactions that indicate diffi-
cult but important issues. A computer software package
will be used to manage the data and increase the trans-
parency of the analysis. Deviant cases will be actively
sought throughout the analysis and emerging ideas and
themes modified in response.
Analysis
Power calculation
The primary outcome is reduction in the proportion of
service users treated or detained under a Mental Health
Act section at least once over the 18 month follow-up
period. In the pilot trial, based in London, 26% were
compulsorily admitted over 15 months, equivalent to
30% over 18 months. Routine data for inner city wards
in Birmingham and Manchester show a very similar pro-
portion, on average. Assuming that a clinically impor-
tant reduction would be to at least halve the proportion,
i.e. a reduction in absolute terms by 15% to 15%, 90%
power using a double-sided test with alpha = 0.05
would require 174 in each arm. For the ethnic subgroup
analysis where the baseline compulsory admission rate is
expected to be higher, an achieved subsample of 91 per
arm would give 80% power to detect a difference from
40% to 20%. Given the percentages of service users
likely to be black at each site (from recent MHA use
data), 90 are likely to be found with a sample of 270 per
arm, and the minimum achieved would be about 80
with a slight reduction in power. Loss to follow-up is
likely to be about 15% for the interview data so this
sample size (270) would reduce to an effective 229 per
arm, which would allow standardised effect sizes of 0.3
for the secondary outcomes to be detectable with 90%
power. The total to be recruited would therefore be 540,
or 180 per site
Analysis Plan
The principal analysis of effectiveness will compare the
primary and secondary outcome measures at 18 months,
combined over centres. The proportions admitted to
hospital under a section at follow up will be compared
between randomisation groups using logistic regression
controlling for centre. Other (continuous) outcomes
such as therapeutic alliance and engagement with men-
tal health services will be analysed using analysis of cov-
ariance controlling for baseline (pre-intervention)
measures and centre. Number of admissions will be ana-
lysed using Poisson regression, and time to first admis-
sion using survival analysis. Bed-days and other very
skewed data will be analysed using bootstrapping to
obtain confidence intervals and p-values [28]. Short
scales will be analysed using ordered logistic regression.
An intention-to-treat analysis will be applied in the first
instance (i.e. analysing all available data from service
users as randomised). Time trends in measures available
at baseline and two time points will be analysed using
methods for longitudinal data such as random effects
regression. Sensitivity analyses will be performed to
assess the influence of loss to follow-up and refusals,
including imputation of missing baseline values from
the within-centre means; multiple imputation of follow
up values (where feasible from other variables) and
CACE analyses [29].
Health Economic analysis plan
The JCP intervention will be costed using recognised
micro-costing methods [30]. Costs will be based on the
mid-point of the salary scale of the relevant JCP profes-
sionals, including all employer costs (National Insurance
and Superannuation contributions) and appropriate
overhead costs (capital, administration, managerial etc).
Other services will be costed using locally applicable
estimates of long-run marginal opportunity costs.
Where necessary, these will be supplemented by pub-
lished national unit costs [31]. Nationally applicable unit
costs will be applied in sensitivity analysis to assess the
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generalisability of the cost results to the UK as a whole.
Productivity losses will be costed using the human capi-
tal approach, which involves multiplying days off work
due to illness by the individual’s salary level [32]. A
number of commentators have argued that this
approach is limited since it tends to overestimate pro-
ductivity losses by ignoring, for example, the ability to
replace workers from the pool of unemployed people
[33]. Given these limitations, the impact of varying pro-
ductivity losses will be explored in sensitivity analysis.
The mean costs in the two groups will be compared
with confidence intervals for mean differences estimated
using bootstrapping controlling for centre and baseline
costs. Future costs and outcomes will not be discounted
in the main analyses because the single follow-up point
will not allow costs that fall within the first 12 months
to be separated from those which occur subsequently.
However, the potential impact of excluding discounting
will be explored in sensitivity analyses. Cost-effective-
ness will be explored using the proportion admitted
under a section over the 18-month follow-up period.
Incremental cost-effectiveness ratios (of the additional
costs to the additional effects of the JCP process in
comparison to the control group) [34] will be reported
and cost-effectiveness acceptability curves showing the
probability that the JCP is more cost-effective than the
control condition will be plotted [35]. Supplementary
evaluation will take the form of a cost-consequences
analysis examining total costs in relation to all other
secondary outcomes. SPSS version 12 and Stata version
9 will be used for the analyses.
Discussion
Previous data shows that the Joint Crisis Plan interven-
tion could halve compulsory treatment under the Men-
tal Health Act and has a high probability of being cost
effective. The Joint Crisis Plan intervention therefore
offers a potential solution to the rise of compulsory
treatment for individuals with psychotic disorders. If
shown to be effective in this trial, it is likely Joint Crisis
Plans will have wide implications for practice and invol-
ving service users in their care.
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